Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion
Authors:
- 2 June 2011
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 34 (1) , 103-105
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset dataAlimentary Pharmacology & Therapeutics, 2011
- Review article: the modern management of hepatic encephalopathyAlimentary Pharmacology & Therapeutics, 2010
- Spectrum of neurocognitive impairment in cirrhosisHepatology, 2009
- Night‐time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosisLiver International, 2009
- Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and AppetiteAnnals of Internal Medicine, 2004
- Ghrelin promotes slow-wave sleep in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998Hepatology, 2002
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999
- High prevalence of sleep disturbance in cirrhosisHepatology, 1998